Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - HI TECH PHARMACAL CO INC | d10q.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - HI TECH PHARMACAL CO INC | dex311.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - HI TECH PHARMACAL CO INC | dex312.htm |
Exhibit 32
HI-TECH PHARMACAL CO., INC.
CERTIFICATION PURSUANT TO 18 U. S. C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Hi-Tech Pharmacal Co., Inc. (the “Company”), hereby certify to such officers’ knowledge, that the Company’s Quarterly Report on Form 10-Q for the period ended January 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 12, 2010
| By: | /s/ David S. Seltzer | |
| David S. Seltzer | ||
| Chief Executive Officer | ||
| By: | /s/ William Peters | |
| William Peters | ||
| Chief Financial Officer | ||
This certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.